Recommended Pages at merck.com
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on November 14, 2011 at 6:12 pm By:
Global Network Health Organization
Great news! Colombia has eliminated river blindness within its borders http://t.co/7MCGo6XI @Merck #NTDs
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on October 28, 2011 at 11:13 am By:
Januvia, Janumet up 40%-plus; Victrelis at $31M, $53M YTD RT @Merck: Announcing 3Q financial results. http://t.co/k1KCYZ8q $MRK #pharma
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on July 29, 2011 at 12:21 pm By:
Lisa Jarvis Science Enthusiast
Yikes, Merck cutting another 12-13% of workforce by end of 2015 to up restructuring savings by $1.3-$1.5b: http://t.co/79z2vBp $MRK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on July 1, 2011 at 2:27 pm By:
eyeonfda Pharma and Health Lawyer
Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan http://ow.ly/5uNvl
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on June 13, 2011 at 11:50 am By:
Lisa Jarvis Science Enthusiast
PR on Merck/Hanwha biosimilar deal from last night: http://t.co/5VLJOAd $MRK
Microsoft Word - CRT-USPPI-MK0476-MF-9989620.doc
merck.com — “Microsoft Word - CRT-USPPI-MK0476-MF-9989620.doc” View full resource at merck.com
Most Recently Shared on May 27, 2011 at 12:11 pm By:
Robyn O'Brien Health Executive
Popular asthma medications contain aspartame, a sweetener linked to cancer & preterm births http://bit.ly/mp7jiw #protectkids
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on May 17, 2011 at 3:47 pm By:
John Carroll Health Communicator
Merck/Roche deal includes agreement on investigating new treatments for hep C. http://bit.ly/lUqNo8
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on April 12, 2011 at 1:33 pm By:
eyeonfda Pharma and Health Lawyer
FDA Approves Merck's SYLATRONâ„¢ (peginterferon alfa-2b) for Injection, Adjuvant Treatment for Melanoma - http://ow.ly/4yq3k
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on April 11, 2011 at 12:11 pm By:
Lisa Jarvis Science Enthusiast
Merck & Indian firm Sun Pharma establish JV to sell branded generics in emerging markets: http://bit.ly/gyzpiw $MRK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on April 7, 2011 at 12:56 pm By:
eyeonfda Pharma and Health Lawyer
U.S. Prescribing Info for GARDASIL® Updated; Indication Not Granted for Use in Adult Women - http://ow.ly/4v8b9
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on January 26, 2011 at 9:22 pm By:
Merck to Acquire SmartCells, Inc http://bit.ly/hlgeFZ
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on January 11, 2011 at 2:39 pm By:
eyeonfda Pharma and Health Lawyer
Merck Gets FDA Acceptance of NDA for Investigational Extended-Release Formulation of JANUMET® #Diabetes http://ow.ly/3BOiG
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on January 6, 2011 at 2:22 pm By:
Lisa Jarvis Science Enthusiast
Merck says NDA for HCV drug boceprevir is accepted in US and EU w/priority review. $VRTX? telaprevir status?: http://bit.ly/fS34ob $MRK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on December 14, 2010 at 12:08 pm By:
Lisa Jarvis Science Enthusiast
PATH, Merck & NYU collaborate on #malaria vaccine targeting novel part of circumsporozoite protein http://bit.ly/eJ5eIG $MRK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on December 2, 2010 at 1:53 pm By:
Lisa Jarvis Science Enthusiast
Merck buys SmartCells, glucose-responsive insulin tech coming out of MIT, for up to $500m: http://bit.ly/i5A9cC
